Similar articles

• [Renin-angiotensin system inhibitors - biochemical and clinical aspects].

  Kuska J, Germakowska-Kowalik T, Pluta S. Kuska J, et al. Postepy Hig Med Dosw. 1982 Jul-Aug;35(4):395-411. Postepy Hig Med Dosw. 1982. PMID: 6183653 Review. Polish. No abstract available.
• Treatment of hypertension with angiotensin converting enzyme inhibitors.

  Johnston CI, McGrath BP, Matthews PG, Jackson B. Johnston CI, et al. Clin Exp Pharmacol Physiol Suppl. 1982;7:135-44. Clin Exp Pharmacol Physiol Suppl. 1982. PMID: 6183036 No abstract available.
• Effects of angiotensin converting enzyme inhibitor and angiotensin II analogue on hypertension. Study of hypertension with two different blockers of the renin-angiotensin-aldosterone system.

  Kodama K, Morotomi Y, Kida O, Higa T, Someya N, Kondo K, Tanaka K. Kodama K, et al. Nihon Jinzo Gakkai Shi. 1985 Mar;27(3):353-61. Nihon Jinzo Gakkai Shi. 1985. PMID: 2991636 No abstract available.
• [Role of renin-angiotensin system and its blockaders in the pathogenesis of arterial hypertension].

  Dimitrov T. Dimitrov T. Eksp Med Morfol. 1982;21(1):1-5. Eksp Med Morfol. 1982. PMID: 6178577 Review. Bulgarian. No abstract available.
• Angiotensin inhibitors for hypertension.

  Gavras H, Gavras I, Brunner HR. Gavras H, et al. Compr Ther. 1980 May;6(5):14-8. Compr Ther. 1980. PMID: 6155240